Cargando…

Pulmonary Localization Revealing Wegener's Granulomatosis

Wegener's granulomatosis (WG) is the most frequent antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis. It affects mainly the upper airways, lungs, and kidneys. Two forms are identified: systemic and limited. We describe three cases of limited WG diagnosed during a 7-year period. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Mlika, Mona, Ayadi-Kaddour, Aida, Marghli, Adel, Kilani, Tarek, El Mezni, Faouzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763831/
https://www.ncbi.nlm.nih.gov/pubmed/20454762
http://dx.doi.org/10.1100/tsw.2010.84
_version_ 1783291961882443776
author Mlika, Mona
Ayadi-Kaddour, Aida
Marghli, Adel
Kilani, Tarek
El Mezni, Faouzi
author_facet Mlika, Mona
Ayadi-Kaddour, Aida
Marghli, Adel
Kilani, Tarek
El Mezni, Faouzi
author_sort Mlika, Mona
collection PubMed
description Wegener's granulomatosis (WG) is the most frequent antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis. It affects mainly the upper airways, lungs, and kidneys. Two forms are identified: systemic and limited. We describe three cases of limited WG diagnosed during a 7-year period. Our aim is to report three localized forms of WG and to put emphasis on the necessity of differentiating localized from systemic forms because of their different prognoses and manner of management. Our study contained two men and one woman with a mean age of 43 years. All our patients were symptomatic and presented with nonspecific respiratory signs. The cANCA were positive in all patients. The imaging findings consisted of cavitary masses. The diagnosis was based on surgical lung biopsy in all cases. All patients were put on cyclophosphamide and prednisolone. Only one patient presented with renal complications after a 2-year follow-up period. The two other patients did not present complications after, respectively, 1 month and 1 year of follow-up. These case reports put emphasis on a rare form of WG, the limited form. The low number of patients, due to the rarity of this disease, does not allow us to delineate the characteristics and the differences between this form and the systemic form, but we highlight the necessity of future investigations in order to explore the pathogenesis, therapeutic, and prognosis differences between these two subsets.
format Online
Article
Text
id pubmed-5763831
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher TheScientificWorldJOURNAL
record_format MEDLINE/PubMed
spelling pubmed-57638312018-06-03 Pulmonary Localization Revealing Wegener's Granulomatosis Mlika, Mona Ayadi-Kaddour, Aida Marghli, Adel Kilani, Tarek El Mezni, Faouzi ScientificWorldJournal Case Study Wegener's granulomatosis (WG) is the most frequent antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis. It affects mainly the upper airways, lungs, and kidneys. Two forms are identified: systemic and limited. We describe three cases of limited WG diagnosed during a 7-year period. Our aim is to report three localized forms of WG and to put emphasis on the necessity of differentiating localized from systemic forms because of their different prognoses and manner of management. Our study contained two men and one woman with a mean age of 43 years. All our patients were symptomatic and presented with nonspecific respiratory signs. The cANCA were positive in all patients. The imaging findings consisted of cavitary masses. The diagnosis was based on surgical lung biopsy in all cases. All patients were put on cyclophosphamide and prednisolone. Only one patient presented with renal complications after a 2-year follow-up period. The two other patients did not present complications after, respectively, 1 month and 1 year of follow-up. These case reports put emphasis on a rare form of WG, the limited form. The low number of patients, due to the rarity of this disease, does not allow us to delineate the characteristics and the differences between this form and the systemic form, but we highlight the necessity of future investigations in order to explore the pathogenesis, therapeutic, and prognosis differences between these two subsets. TheScientificWorldJOURNAL 2010-05-04 /pmc/articles/PMC5763831/ /pubmed/20454762 http://dx.doi.org/10.1100/tsw.2010.84 Text en Copyright © 2010 Mona Mlika et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Study
Mlika, Mona
Ayadi-Kaddour, Aida
Marghli, Adel
Kilani, Tarek
El Mezni, Faouzi
Pulmonary Localization Revealing Wegener's Granulomatosis
title Pulmonary Localization Revealing Wegener's Granulomatosis
title_full Pulmonary Localization Revealing Wegener's Granulomatosis
title_fullStr Pulmonary Localization Revealing Wegener's Granulomatosis
title_full_unstemmed Pulmonary Localization Revealing Wegener's Granulomatosis
title_short Pulmonary Localization Revealing Wegener's Granulomatosis
title_sort pulmonary localization revealing wegener's granulomatosis
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763831/
https://www.ncbi.nlm.nih.gov/pubmed/20454762
http://dx.doi.org/10.1100/tsw.2010.84
work_keys_str_mv AT mlikamona pulmonarylocalizationrevealingwegenersgranulomatosis
AT ayadikaddouraida pulmonarylocalizationrevealingwegenersgranulomatosis
AT marghliadel pulmonarylocalizationrevealingwegenersgranulomatosis
AT kilanitarek pulmonarylocalizationrevealingwegenersgranulomatosis
AT elmeznifaouzi pulmonarylocalizationrevealingwegenersgranulomatosis